Nexium Articles

AstraZeneca files for US approval of OTC Losec

31 August 2000

AstraZeneca reveals UK pricing for Nexium

10 August 2000

AstraZeneca reveals pricing strategy for Nexium, lower than Losec

2 August 2000

AstraZeneca 1st-half 2000 sales up 8% as firm prepares for blockbuster

1 August 2000

Losec follow-up Nexium gains approval in EU

13 July 2000

AstraZeneca reveals new Nexium vs Losec data in bid to show superiority

21 June 2000

Upbeat presentations marks Goldman Sachs' health care conference

20 June 2000

Stock Commentary Europe

25 May 2000

AstraZeneca's Nexium, new data do not change outlook, says GS

24 May 2000

AHP gains Mylotarg approval in USA, first launch shortly

19 May 2000

Stock Commentary Europe

11 May 2000

Stock Commentary Europe and London

4 May 2000

AstraZeneca sees 17% 1st qtr pretax growth

3 May 2000

AstraZeneca falls again on confusion over Losec follow-up

2 May 2000

AstraZeneca falls again on confusion over Losec follow-up

28 April 2000

Stock Commentary Europe

16 March 2000

Concern over US DTC ad info request

15 March 2000

AstraZeneca gets first approval for omeprazole follow-up Nexium

14 March 2000

Life after Losec at AstraZeneca

29 February 2000

Stock Commentary Europe

16 December 1999

Stock Commentary Europe

9 December 1999

AstraZeneca sees future in "mega-drugs," $1 billion-plus sales potential

8 December 1999

AstraZeneca files for new generation PPI

6 December 1999

Showing 201-223 of 223 articles

Go to beginningPreviousNextGo to end